Back
AbCellera Biologics, Inc. Stock Predictions
Missed $0.81? RAD Intel Now Open at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
31
ABCL
AbCellera Biologics, Inc.
Last Price:
$3.56
Seasonality Move:
-22.66%
7 Day Trial
ALL ACCESS PASS
$
7
Still Time to Get In: RAD Intel at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiAbCellera Biologics, Inc. Stock Forecast
-
Is AbCellera Biologics, Inc. Stock Undervalued?The current AbCellera Biologics, Inc. [ABCL] share price is $3.56. The Score for ABCL is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
-
ABCL is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will AbCellera Biologics, Inc. Stock Go Up Next Year?
Data Unavailable
AbCellera Biologics, Inc. Stock Rating
Data Unavailable
AbCellera Biologics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
Canada
Industry:
Life Sciences Tools & Services
Sector:
Health Care
Type:
stock
Website:
abcellera.com
52-Week Data
52-Week High:
6.52
52-Week Low:
1.89
Prediction Charts
Market Cap:
1.1B
Price in USD:
3.56
Volume:
2.3M
Beta:
0.74
Technical Analysis
SMA50:
4.79
SMA100:
4.63
SMA200:
3.65
52-Wk Change:
24.91%
Stock Predictions
-
Is AbCellera Biologics, Inc. stock public?Yes, AbCellera Biologics, Inc. is a publicly traded company.
-
What is the AbCellera Biologics, Inc. stock quote today?The AbCellera Biologics, Inc. stock price is 3.56 USD today.
-
How to buy AbCellera Biologics, Inc. stock online?You can buy AbCellera Biologics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-17 | 3.66 | 3.60 | 3.72 | 3.52 |
| Nov-18 | 3.54 | 3.66 | 3.70 | 3.46 |
| Nov-19 | 3.69 | 3.61 | 3.81 | 3.57 |
| Nov-20 | 3.72 | 3.41 | 3.83 | 3.39 |
| Nov-21 | 3.42 | 3.51 | 3.55 | 3.33 |
| Nov-24 | 3.51 | 3.57 | 3.60 | 3.46 |
| Nov-25 | 3.57 | 3.62 | 3.68 | 3.49 |
| Nov-26 | 3.64 | 3.64 | 3.78 | 3.54 |
| Nov-28 | 3.73 | 3.73 | 3.76 | 3.64 |
| Dec-1 | 3.61 | 3.47 | 3.65 | 3.46 |
| Dec-2 | 3.47 | 3.46 | 3.52 | 3.42 |
| Dec-3 | 3.46 | 3.49 | 3.57 | 3.44 |
| Dec-4 | 3.48 | 3.65 | 3.74 | 3.45 |
| Dec-5 | 3.63 | 3.56 | 3.69 | 3.53 |
AbCellera Biologics, Inc. Earnings
Data Unavailable
AbCellera Biologics, Inc. Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.06 per share, and a decrease next year of $0.04 per share.
* AbCellera Biologics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.